retatrutide weight loss retatrutide clinical trial VisualAbstract: reduces body by 17.5% in patients with obesity New Phase 3 retatrutide data
Description
But weight loss varied based on when a person stopped taking the drugs, researchers found
Therefore, diabetic patients with acromegaly could be treated with SGLT-2i, albeit caution is required for patients with uncontrolled disease
[DOI] [PubMed] [Google Scholar] Baggio LL, Drucker DJ
(2007a)
